Search research articles
Contact Us
Filters
Showing results (181-190 of 207) with videos related to
Page
of 21
Sort By:
European Heart Journal
|
November 11, 2017
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Alexander Niessner, Juan Tamargo, Lorenz Koller, et al.
European Heart Journal
|
September 10, 2013
High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality
Guenther Silbernagel, Ben Schöttker, Sebastian Appelbaum, et al.
European Heart Journal
|
January 13, 2017
Comprehensive efforts to increase adherence to statin therapy
Alexander Vonbank, Stefan Agewall, Keld Per Kjeldsen, et al.
Wiener Klinische Wochenschrift
|
April 2, 2026
[Consensus statement of the Austrian Society for Rheumatology and Rehabilitation on the management of increased cardiovascular risk in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis]
Boris Lindner, Mathias Ausserwinkler, Christina Siess, et al.
Circulation. Heart Failure
|
August 15, 2015
Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction
Lorenz Koller, Marcus E Kleber, Vincent M Brandenburg, et al.
European Heart Journal
|
December 26, 2015
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis
Alexander Niessner, Juan Tamargo, João Morais, et al.
Plos One
|
April 8, 2015
Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease
Konstantin A Krychtiuk, Stefan P Kastl, Stefan Pfaffenberger, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 29, 2022
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Juan Tamargo, Keld Per Kjeldsen, Eva Delpón, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
November 2, 2020
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials
Heinz Drexel, Basil S Lewis, Giuseppe M C Rosano, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 24, 2019
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Patrick Sulzgruber, Sven Wassmann, Anne Grete Semb, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 207) with videos related to
Sort By:
Page
of 21
European Heart Journal
|
November 11, 2017
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Alexander Niessner, Juan Tamargo, Lorenz Koller, et al.
European Heart Journal
|
September 10, 2013
High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality
Guenther Silbernagel, Ben Schöttker, Sebastian Appelbaum, et al.
European Heart Journal
|
January 13, 2017
Comprehensive efforts to increase adherence to statin therapy
Alexander Vonbank, Stefan Agewall, Keld Per Kjeldsen, et al.
Wiener Klinische Wochenschrift
|
April 2, 2026
[Consensus statement of the Austrian Society for Rheumatology and Rehabilitation on the management of increased cardiovascular risk in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis]
Boris Lindner, Mathias Ausserwinkler, Christina Siess, et al.
Circulation. Heart Failure
|
August 15, 2015
Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction
Lorenz Koller, Marcus E Kleber, Vincent M Brandenburg, et al.
European Heart Journal
|
December 26, 2015
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis
Alexander Niessner, Juan Tamargo, João Morais, et al.
Plos One
|
April 8, 2015
Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease
Konstantin A Krychtiuk, Stefan P Kastl, Stefan Pfaffenberger, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 29, 2022
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Juan Tamargo, Keld Per Kjeldsen, Eva Delpón, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
November 2, 2020
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials
Heinz Drexel, Basil S Lewis, Giuseppe M C Rosano, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 24, 2019
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Patrick Sulzgruber, Sven Wassmann, Anne Grete Semb, et al.
Page
of 21